Minims Tetracainehydrochloride (Tetracaine Hydrochloride)

Tetracaine hydrochloride, the active ingredient in Minims Tetracainehydrochloride, is a local anesthetic presented as a sterile ophthalmic solution for ocular use. It provides rapid corneal anesthesia for diagnostic examinations and surgical procedures in patients requiring temporary loss of ocular sensation.

GNH USA supplies Minims Tetracainehydrochloride as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent batch release testing and regulatory compliance across all markets.

Tetracaine hydrochloride is used in ophthalmology to provide topical anesthesia for corneal and ocular surface procedures.

- Diagnostic ocular procedures: provides rapid corneal anesthesia to facilitate slit‑lamp examination and fluorescein staining. - Surgical ocular procedures: enables painless manipulation of the cornea during minor surgeries such as foreign‑body removal. - Corneal anesthesia: offers temporary relief of discomfort during corneal abrasions or ulcer assessments.

Topical ocular application of tetracaine may be associated with a range of adverse ocular reactions.

Common Side Effects: - Transient stinging or burning sensation. - Mild conjunctival hyperemia. - Temporary blurred vision.

Serious or Rare Side Effects: - Corneal epithelial toxicity or ulceration. - Allergic contact keratitis. - Severe ocular inflammation or uveitis.

When using tetracaine ophthalmic solution, several precautions should be observed to ensure safety and efficacy.

- Allergy assessment: confirm no known hypersensitivity to ester‑type local anesthetics. - Corneal integrity: avoid use on severely damaged epithelium unless directed by an ophthalmologist. - Concurrent ocular medications: evaluate for additive toxicity with other topical agents. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk, as safety data are limited. - Store at room temperature below 25°C: keep in the original container, protect from light and moisture.

Tetracaine ophthalmic solution can interact with other ocular or systemic agents.

Major Interactions (Avoid): - Topical ophthalmic antibiotics: may increase risk of corneal toxicity when used concurrently. - Other local anesthetic eye drops: additive anesthetic effect can lead to excessive corneal numbness.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: monitor intraocular pressure as anesthetic may mask pressure changes. - Anticholinergic eye drops: observe for delayed corneal healing. - Systemic sodium channel blockers (e.g., antiarrhythmics): watch for potential systemic effects if large ocular surface area is treated.